Adherence with metreleptin therapy and health self-perception in patients with lipodystrophic syndromes

[1]  M. Fasshauer,et al.  Facial soft tissue volume decreases during metreleptin treatment in patients with partial and generalized lipodystrophy , 2017, Endocrine.

[2]  D. Dunger,et al.  The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline , 2016, The Journal of clinical endocrinology and metabolism.

[3]  C. Musso,et al.  Metreleptin Treatment in Three Patients with Generalized Lipodystrophy , 2016, Clinical medicine insights. Case reports.

[4]  F. Travert,et al.  One‐year metreleptin improves insulin secretion in patients with diabetes linked to genetic lipodystrophic syndromes , 2016, Diabetes, obesity & metabolism.

[5]  E. Madrid,et al.  Association of glycaemia with perceived threat of illness in patients with type 2 diabetes. , 2015, Primary care diabetes.

[6]  M. Rijken,et al.  Illness perceptions of cancer patients: relationships with illness characteristics and coping , 2015, Psycho-oncology.

[7]  D. Frizelle,et al.  Illness perceptions, mood and quality of life: a systematic review of coronary heart disease patients. , 2013, Journal of psychosomatic research.

[8]  A. Wittkowski,et al.  A Systematic Review of the Literature Exploring Illness Perceptions in Mental Health Utilising the Self-Regulation Model , 2013, Journal of Clinical Psychology in Medical Settings.

[9]  R. Moss‐Morris,et al.  Illness perceptions and glycaemic control in diabetes: a systematic review with meta‐analysis , 2011, Diabetic medicine : a journal of the British Diabetic Association.

[10]  E. Martinez,et al.  Lipodystrophy and quality of life of HIV-infected persons. , 2008, AIDS reviews.

[11]  M. Atkinson,et al.  Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers. , 2005, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[12]  S. Abbey,et al.  The relationship between lipodystrophy-associated body changes and measures of quality of life and mental health for HIV-positive adults , 2005, Quality of Life Research.

[13]  Esteban Martínez,et al.  Impact of lipodystrophy on the quality of life of HIV-1-infected patients. , 2002, Journal of acquired immune deficiency syndromes.

[14]  O. Hanon,et al.  Evaluation de l'observance du traitement antihypertenseur par un questionnaire : mise au point et utilisation dans un service spécialisé , 2001 .

[15]  J. D. de Wit,et al.  The impact of experiencing lipodystrophy on the sexual behaviour and well-being among HIV-infected homosexual men. , 2001, AIDS.

[16]  P. Stanley,et al.  Illness perceptions and mood in chronic fatigue syndrome. , 2001, Journal of psychosomatic research.

[17]  J. Treasure,et al.  Perceptions of illness in individuals with anorexia nervosa: a comparison with lay men and women. , 2005, The International journal of eating disorders.

[18]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[19]  O. Hanon,et al.  [Assessment of antihypertensive compliance using a self-administered questionnaire: development and use in a hypertension clinic]. , 2001, Presse medicale.

[20]  J. Gatell,et al.  Lipodystrophy Syndrome in Patients with HIV Infection , 2001, Drug safety.

[21]  S. O’Rahilly,et al.  Dunnigan-Kobberling syndrome: an autosomal dominant form of partial lipodystrophy. , 1997, QJM : monthly journal of the Association of Physicians.